BrainAurora-B Schedules 18 June 2026 Virtual AGM; Seeks 20% Share-Issuance and 10% Buy-Back Mandates

BrainAurora Medical Technology Limited (BrainAurora-B, 06681.HK) has issued a notice convening its 2026 Annual General Meeting (AGM) for 18 June 2026 at 10:00 a.m., to be conducted entirely online.

Key agenda items

1. Financial statements • Shareholders will vote on the adoption of the audited consolidated financial statements for the year ended 31 December 2025 together with the directors’ and auditor’s reports.

2. Board composition • Five directors are standing for re-election: non-executive directors Mr Deng Feng, Mr Yang Fan and Ms Wang Jingbo, and independent non-executive directors Dr Duan Tao and Mr Tu Lei.

3. Remuneration and auditor • The board seeks authority to determine directors’ remuneration. • Deloitte Touche Tohmatsu is nominated for re-appointment as external auditor, with fees to be fixed by the board.

4. General mandates • Share issuance: Directors request a fresh mandate to allot, issue or deal with additional shares—including sales or transfers of treasury shares—up to 20% of the company’s issued share capital (excluding treasury shares) during the mandate period. • Share buy-back: A separate mandate would allow repurchases of up to 10% of issued shares (excluding treasury shares) on the Hong Kong Stock Exchange or other recognised venues. • Extension: Subject to both mandates passing, the issuance limit may be increased by the number of shares repurchased, effectively adding up to a further 10% capacity. • The board states it has no immediate plans to issue new shares and will exercise any buy-back authority only when deemed beneficial to shareholders.

Procedural details

• Register closure: 15–18 June 2026 (both days inclusive). Share transfer documents must be lodged by 4:30 p.m. on 12 June 2026 to qualify for AGM attendance and voting. • Proxy deadline: 10:00 a.m. on 16 June 2026. Shareholders may appoint proxies; joint holders receive one login for the virtual meeting via the Vistra eVoting Portal. • Non-registered shareholders holding shares through CCASS should liaise with their intermediaries to arrange attendance and voting.

Corporate information

As of the notice date (28 April 2026), BrainAurora’s board comprises one executive director (Mr Tan Zheng, Chairman), three non-executive directors (Mr Deng Feng, Mr Yang Fan, Ms Wang Jingbo) and three independent non-executive directors (Mr Lam Yiu Por, Dr Duan Tao, Mr Tu Lei).